{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:48:46Z","timestamp":1775674126333,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.nrleng.2026.501921","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:37:34Z","timestamp":1775669854000},"page":"501921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Parkinson's Real-World Impact Assessment (PRISM) project in the management and burden of Parkinson's disease in Spain"],"prefix":"10.1016","volume":"41","author":[{"given":"C.","family":"Painous Mart\u00ed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Pijuan Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c0.","family":"Bay\u00e9s Rusi\u00f1ol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Mart\u00ednez Castrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"S\u00e9sar Ignacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tolosa Sarr\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2026.501921_bib0215","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JPD-202078","article-title":"Recommendations for the organization of multidisciplinary clinical care teams in Parkinson's disease","volume":"10","author":"Radder","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.nrleng.2026.501921_bib0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2217\/nmt.15.16","article-title":"Behavioral treatments for speech in Parkinson's disease: meta-analyses and review of the literature","volume":"5","author":"Atkinson-Clement","year":"2015","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.nrleng.2026.501921_bib0225","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1474-4422(14)70055-9","article-title":"Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trial","volume":"13","author":"Sturkenboom","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2026.501921_bib0230","doi-asserted-by":"crossref","first-page":"e5004","DOI":"10.1136\/bmj.e5004","article-title":"Physiotherapy intervention in Parkinson's disease: systematic review and meta-analysis","volume":"345","author":"Tomlinson","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.nrleng.2026.501921_bib0235","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1474-4422(20)30036-3","article-title":"Initiation of pharmacological therapy in Parkinson's disease: when, why, and how","volume":"19","author":"de Bie","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2026.501921_bib0240","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9106026","article-title":"Direct cost of Parkinson's disease: a real-world data study of second-line therapies","author":"Gomez-Inhiesto","year":"2020","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.nrleng.2026.501921_bib0245","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4321\/S1137-66272014000100008","article-title":"Key elements for patients and caregivers in the process of living with Parkinson's disease","volume":"37","author":"Zaragoza Salcedo","year":"2014","journal-title":"An Sist Sanit Navar"},{"issue":"Suppl. 1","key":"10.1016\/j.nrleng.2026.501921_bib0250","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.21037\/apm.2019.10.01","article-title":"Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach","volume":"9","author":"Macchi","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.nrleng.2026.501921_bib0255","article-title":"Present and future of Parkinson's disease in Spain: PARKINSON-2030 Delphi project","volume":"11","author":"Santos Garc\u00eda","year":"1931","journal-title":"Brain Sci"},{"key":"10.1016\/j.nrleng.2026.501921_bib0260","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3233\/JPD-212611","article-title":"The Parkinson's Real-World Impact Assessment (PRISM) study: a European survey of the burden of Parkinson's disease in patients and their carers","volume":"11","author":"Tolosa","year":"2021","journal-title":"J Parkinsons Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.nrleng.2026.501921_bib0265","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/PL00007737","article-title":"Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders","volume":"245","author":"Mart\u00ednez-Mart\u00edn","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2026.501921_bib0270","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0275","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive\u2013compulsive disorders in Parkinson's disease-rating scale","volume":"27","author":"Weintraub","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0280","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.clineuro.2009.07.018","article-title":"A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: the ROPI-PARK study","volume":"111","author":"Valldeoriola","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.nrleng.2026.501921_bib0285","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1008928321652","article-title":"Evaluation of a measurement strategy for Parkinson's disease: assessing patient health-related quality of life","volume":"9","author":"Damiano","year":"2000","journal-title":"Qual Life Res"},{"key":"10.1016\/j.nrleng.2026.501921_bib0290","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.21355","article-title":"Caregiver burden in Parkinson's disease","volume":"22","author":"Mart\u00ednez-Mart\u00edn","year":"2015","journal-title":"Mov Disord"},{"issue":"Pt 10","key":"10.1016\/j.nrleng.2026.501921_bib0295","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/brain\/awu195","article-title":"The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa","volume":"137","author":"Cilia","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2026.501921_bib0300","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(14)60683-8","article-title":"Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial","volume":"384","author":"Gray","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2026.501921_bib0305","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.parkreldis.2008.07.004","article-title":"Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis","volume":"15","author":"Baker","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0310","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12913-017-2090-x","article-title":"Clinical trials from the patient perspective: survey in an online patient community","volume":"17","author":"DasMahapatra","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.nrleng.2026.501921_bib0315","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7861\/clinmedicine.12-3-210","article-title":"Analysis and validation of a Parkinson's disease register as a recruitment tool for clinical studies","volume":"12","author":"Carroll","year":"2012","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.nrleng.2026.501921_bib0320","doi-asserted-by":"crossref","unstructured":"Chowdhury S, Meunier CC, Cappelletti L, Sherer T. Improving patient participation in Parkinson's clinical trials: the experience of the Michael J Fox Foundation. Clin Invest. 2014;4(2):185\u201392.","DOI":"10.4155\/cli.13.127"},{"key":"10.1016\/j.nrleng.2026.501921_bib0325","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/906274","article-title":"Recurrent falls in Parkinson's disease: a systematic review","author":"Allen","year":"2013","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.nrleng.2026.501921_bib0330","series-title":"Encuesta sobre P\u00e1rkinson observando calidad asistencial 2012","year":"2023"},{"key":"10.1016\/j.nrleng.2026.501921_bib0335","unstructured":"Sociedad Espa\u00f1ola de Neurolog\u00eda. Gu\u00edas Diagn\u00f3sticas y Terap\u00e9uticas de La Sociedad Espa\u00f1ola de Neurolog\u00eda. Gu\u00eda Oficial de Recomendaciones Cl\u00ednicas En La Enfermedad de Parkinson [accessed 7.6.23]."},{"key":"10.1016\/j.nrleng.2026.501921_bib0340","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1212\/WNL.0000000000002670","article-title":"Quality improvement in neurology: Parkinson disease update quality measurement set: executive summary","volume":"86","author":"Factor","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2026.501921_bib0345","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.22377","article-title":"Allied health care in Parkinson's disease: referral, consultation, and professional expertise","volume":"24","author":"Nijkrake","year":"1930","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0350","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nrl.2013.04.008","article-title":"The social impact of Parkinson's disease in Spain: report by the Spanish Foundation for the Brain","volume":"31","author":"Garc\u00eda-Ramos","year":"2016","journal-title":"Neurologia"},{"key":"10.1016\/j.nrleng.2026.501921_bib0355","article-title":"Predictive model of quality of life in patients with Parkinson's disease","volume":"19","author":"Candel-Parra","year":"2007","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.nrleng.2026.501921_bib0360","article-title":"Falls predict acute hospitalization in Parkinson's disease","author":"Santos Garc\u00eda","year":"2007","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.nrleng.2026.501921_bib0365","unstructured":"Unidad de urgencias hospitalarias. Est\u00e1ndares y recomendaciones. https:\/\/www.sanidad.gob.es\/organizacion\/sns\/planCalidadSNS\/docs\/UUH.pdf [accessed 30.9.23]."},{"key":"10.1016\/j.nrleng.2026.501921_bib0370","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.parkreldis.2015.01.017","article-title":"Measuring the burden and mortality of hospitalisation in Parkinson's disease: a cross-sectional analysis of the English Hospital Episodes Statistics database 2009\u20132013","volume":"21","author":"Low","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0375","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/mds.22121","article-title":"Predictors and course of health-related quality of life in Parkinson's disease","volume":"23","author":"Forsaa","year":"1930","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0380","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease","volume":"26","author":"Martinez-Martin","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0385","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41531-021-00256-w","article-title":"Predictors of clinically significant quality of life impairment in Parkinson's disease","volume":"7","author":"Santos Garc\u00eda","year":"2016","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.nrleng.2026.501921_bib0390","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/ene.14008","article-title":"COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation","volume":"26","author":"Santos Garc\u00eda","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrleng.2026.501921_bib0395","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive\u2013compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"1930","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0400","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1212\/CPJ.0000000000200074","article-title":"Online vs face-to-face administration of impulse control disorder questionnaires in Parkinson disease: does method matter?","volume":"12","author":"Scott","year":"2022","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.nrleng.2026.501921_bib0405","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ane.12305","article-title":"Factors contributing to caregivers\u2019 stress and burden in Parkinson's disease","volume":"131","author":"Santos-Garc\u00eda","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrleng.2026.501921_bib0410","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/scs.12408","article-title":"Profiles of Alzheimer's caregivers in Spain: social, educational and laboral characteristics","volume":"31","author":"Ruiz-Adame Reina","year":"2017","journal-title":"Scand J Caring Sci"},{"key":"10.1016\/j.nrleng.2026.501921_bib0415","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/mds.22106","article-title":"Burden, perceived health status, and mood among caregivers of Parkinson's disease patients","volume":"23","author":"Martinez-Martin","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.nrleng.2026.501921_bib0420","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.parkreldis.2013.06.005","article-title":"Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients","volume":"19","author":"Carod-Artal","year":"2013","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580826000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T17:38:00Z","timestamp":1775669880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580826000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2173580826000283"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.501921","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Parkinson's Real-World Impact Assessment (PRISM) project in the management and burden of Parkinson's disease in Spain","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2026.501921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501921"}}